China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company employs 6,141 full-time employees The company went IPO on 2010-09-28. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.
Follow-Up Questions
CHSYF 股票的價格表現如何？
CHSYF 的當前價格為 $0，在上個交易日 decreased 了 0%。
China Medical System Holdings Ltd 的主要業務主題或行業是什麼？
China Medical System Holdings Ltd 屬於 Pharmaceuticals 行業，該板塊是 Health Care
China Medical System Holdings Ltd 的市值是多少？
China Medical System Holdings Ltd 的當前市值是 $0
China Medical System Holdings Ltd 是買入、賣出還是持有？
據華爾街分析師稱，共有 7 位分析師對 China Medical System Holdings Ltd 進行了分析師評級，包括 2 位強烈買入，7 位買入，2 位持有，0 位賣出，以及 2 位強烈賣出
